Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2025-12-26 @ 11:09 AM
NCT ID:
NCT07220512
Eligibility Criteria:
Inclusion Criteria:
* Ability to understand and willingness to sign an IRB-approved informed consent.
* Age \> 55 years at the time of enrollment.
* Newly diagnosed suspected ovarian/primary peritoneal/fallopian tube carcinoma of any histological subtype, FIGO Stage II-IV, per enrolling investigator, or newly diagnosed suspected endometrial carcinoma of any histologic subtype, FIGO Stage II-IV, per enrolling investigator.
* Planned for 3 or 4 cycles of NACT, with interval cytoreductive surgery planned thereafter.
* Ability to read, understand, and write the English language.
* As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.
Exclusion Criteria:
* History of brain metastases.
* History of poorly controlled psychiatric conditions, defined as hospitalization within the prior 3 months for psychiatric disorders, traumatic brain injury, cerebrovascular event, or dementia, per the enrolling investigator.
* Use of anti-amyloid agents, cholinesterase inhibitors, or glutamate regulators at the time of enrollment.
* Vision impairment that would impede completion of study assessments, per enrolling investigator.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
55 Years
Study:
NCT07220512
Study Brief:
Protocol Section:
NCT07220512